Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ADC Therapeutics (ADCT) Current Leases: 2019-2023

Historic Current Leases for ADC Therapeutics (ADCT) over the last 4 years, with Sep 2023 value amounting to $1.4 million.

  • ADC Therapeutics' Current Leases rose 69.70% to $1.4 million in Q3 2023 from the same period last year, while for Sep 2023 it was $1.4 million, marking a year-over-year increase of 69.70%. This contributed to the annual value of $1.1 million for FY2022, which is 6.61% up from last year.
  • As of Q3 2023, ADC Therapeutics' Current Leases stood at $1.4 million, which was down 13.17% from $1.6 million recorded in Q2 2023.
  • In the past 5 years, ADC Therapeutics' Current Leases ranged from a high of $1.6 million in Q2 2023 and a low of $1,051 during Q3 2020.
  • For the 3-year period, ADC Therapeutics' Current Leases averaged around $1.1 million, with its median value being $1.0 million (2021).
  • Examining YoY changes over the last 5 years, ADC Therapeutics' Current Leases showed a top increase of 96,189.25% in 2021 and a maximum decrease of 25.76% in 2021.
  • ADC Therapeutics' Current Leases (Quarterly) stood at $924,000 in 2019, then reached $1,051 in 2020, then surged by 96,189.25% to $1.0 million in 2021, then grew by 6.61% to $1.1 million in 2022, then skyrocketed by 69.70% to $1.4 million in 2023.
  • Its Current Leases stands at $1.4 million for Q3 2023, versus $1.6 million for Q2 2023 and $1.4 million for Q1 2023.